Buckingham Research lowered its price target on Adient (NYSE: ADNT) to $67.00 (from $74.00) while maintaining a Neutral rating.

Analyst PT Change

Adient (ADNT) PT Lowered to $75 at Morgan StanleyFebruary 1, 2018 7:37 AM Adient (ADNT) PT Lowered to $75 at Wells FargoJanuary 30, 2018 8:34 AM Adient (ADNT) PT Lowered to $73 at BairdJanuary 30, 2018 8:27 AM Adient (ADNT) PT Lowered to $87 at UBSJanuary 30, 2018 8:21 AM Adient (ADNT) PT Lowered to $69 at JPMorganJanuary 30, 2018 7:30 AM Adient (ADNT) PT Lowered to $64 at Guggenheim, 'It Could Get Worse Before It Gets Better'January 30, 2018 6:13 AM Adient (ADNT) PT Lowered to $69 at BarclaysJanuary 30, 2018 4:22 AM